Results 121 to 130 of about 4,207 (149)

[Comparison of setup errors between two immobilization methods in prostate cancer radiotherapy based on cone-beam computed tomography]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Liu J, Ma M, Wang Q, Shi M, Yin J, Wang Z, Shen J, Gao X.   +7 more
europepmc   +1 more source

[Identification and validation of hub genes in prostate cancer progression based on weighted gene co-expression network analysis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2021
Zhang H, Chen N, Wang X, Gao B, Ling M, Chen G, Wu Z, Li Y, Zhong W, Pan B.   +9 more
europepmc   +1 more source

[Advances in the diagnosis of prostate cancer based on image fusion]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Luo W, Wang P, Zhang Y, Shi G.
europepmc   +1 more source

Advancements in molecular imaging probes for precision diagnosis and treatment of prostate cancer. [PDF]

J Zhejiang Univ Sci B
Fang J, Alhaskawi A, Dong Y, Cheng C, Xu Z, Tian J, Abdalbary SA, Lu H.   +7 more
europepmc   +1 more source

Comprehensive single-cell transcriptomic analysis reveals fibroblast subpopulations and the prognostic association of COMT in prostate cancer progression， COMT ， COMT. [PDF]

Sci Rep
Shan W, Guan B, Ma W, Fan R, Cui D, Hao Z.   +5 more
europepmc   +1 more source

[Clinical efficacy of docetaxel combined with carboplatin in patients with metastatic castration-resistant prostate cancer]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2021
Bai GC, Song Y, Jin J, Yu W, He ZS.
europepmc   +1 more source

[Effect of Precise Dissection and Reconstruction of the Prostate Apex and Bladder Neck in Radical Prostatectomy on Urinary Control Improvement]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Wang Y, Tai S, Zhou J, Yang C, Shi H, Chen J, Liang C.   +6 more
europepmc   +1 more source

[Analysis of risk factors for long-term overactive bladder after radical prostatectomy]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Yan Y, Li X, Xia H, Zhu X, Zhang Y, Zhang F, Liu K, Liu C, Ma L.   +8 more
europepmc   +1 more source

[Clinical Value of Dual Tracer PET Imaging With ⁶⁸Ga-PSMA and ¹⁸F-FDG in Patients With Metastatic Prostate Cancer]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Dai H, Huang S, Tian T, Hou N, Zeng H, Wei Q, Huang R.   +6 more
europepmc   +1 more source

[A risk prediction model for prognosis and immunotherapy response in prostate cancer patients based on immunosuppressive neutrophil Neu_2 subsets]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen Z, Zhou J, Tan L, Huang Z, Xue K, Chen M.   +5 more
europepmc   +1 more source